Semax vs Selank: Understanding Two Popular Cognitive Research Peptides

Introduction

Semax and Selank are two synthetic neuropептides developed in Russia, among the most studied nootropic research compounds of their class. Though both target the central nervous system, they do so through fundamentally different mechanisms, producing distinct and often complementary effects in cognitive research models.

Origins and Development

Both peptides were developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. Semax was designed as an ACTH analogue, while Selank was derived from the endogenous anxiety-regulating peptide tuftsin. Both have been approved for medical use in Russia and Ukraine.

What Is Semax?

Semax is a heptapeptide (7 amino acids) analogue of ACTH(4-10), a fragment of adrenocorticotropic hormone. Despite its ACTH origin, Semax does not stimulate cortisol production. Instead, it strongly potentiates BDNF (brain-derived neurotrophic factor) expression and NGF (nerve growth factor) signaling.

What Is Selank?

Selank is a synthetic analogue of the immunomodulatory peptide tuftsin, extended by four additional amino acids to enhance stability. It binds to components of the GABA-A receptor complex and modulates the expression of serotonin, dopamine, and norepinephrine transporters to produce anxiolytic (anxiety-reducing) effects.

Key Differences

Primary axis: Semax targets BDNF/neurotrophin pathways and cognitive activation; Selank targets the GABAergic/serotonergic system for anxiety reduction. Effect profile: Semax is more stimulating and nootropic; Selank is more calming and anxiolytic. Research area: Semax excels in neurodegeneration and cognitive enhancement research; Selank in anxiety, stress, and neuroimmunology models.

BDNF and Neuroprotection

Semax is uniquely effective at elevating BDNF - a growth factor critical to neuronal survival, synaptic plasticity, and memory consolidation. Research models show Semax can rapidly increase BDNF mRNA expression in the hippocampus, making it a powerful tool for studying neuroplasticity and cognitive aging.

Anxiety and Anxiolytic Research

Selank demonstrates anxiolytic effects comparable to benzodiazepines in animal models, but without the sedation, cognitive impairment, or physical dependence associated with that drug class. It also exhibits notable immunomodulatory effects, influencing interleukin expression and T-cell activity.

Conclusion

Semax and Selank represent two distinct approaches to cognitive and neurological research. Their complementary profiles - stimulating vs. calming, neurotrophin vs. GABAergic - make them valuable tools for researchers mapping the broad landscape of CNS peptide pharmacology.